Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase 1 Multiple-Dose Safety, Pharmacokinetic, and Drug Interaction of DIM
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Understanding Myofibroblast Progenitor Fate and Function in Renal Fibrosis
Activation of Clotting &cell adhesion : gas embolism
Adolescent Blood Pressure and Anger - Ethnic Differences
Programs of Excellence in Molecular Biology
In Vivo and IN Vitro B Lymphocyte Activation
Recently added grants:
Overcoming Tumor Resistance with Enzyme-Instructed Nanoscale Assemblies and Immunotherapies
Cancer Center Administration
Addressing protein synthesis regulation within small numbers of discrete neurons
Pharmacological and behavioral effects of MCAM: a long-acting, ? opioid receptor antagonist for treatment of opioid overdose and opioid abuse disorder
Planning and Evaluation
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN35008-12-0-1
Application #
7577651
Study Section
Project Start
2003-02-18
Project End
2008-02-17
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 CA
Phase 1 Multiple-Dose Safety, Pharmacokinetic, and Drug Interaction of DIM
/
$57,513
NIH 2007
N01 CA
Phase 1 Multiple-Dose Safety, Pharmacokinetic, and Drug Interaction Clinical Stu
Hurwityz, Daniel /
$64,187
NIH 2007
N01 CA
Phase 1 Multiple-Dose Safety, Pharmacokinetic, and Drug Interaction of DIM
/
Comments
Be the first to comment on this grant